Cash flow quality remains inconsistent, as evidenced by a dividend payout ratio relative to AFFO that fluctuated from 1.51 in 2024Q4 to 0.52 in 2026Q1, largely due to heavy maintenance CapEx reaching $48.1M in 2025Q4.
| Cash from Operations | 321.88M | 294.44M | 176.09M | 98.53M | 147.77M | 17.91M | 219.16M | 117.45M | 106.81M | 128.1M | 114.36M |
| Operating CF Growth % | 128.08% | 67.21% | 78.7% | -33.32% | 724.92% | -91.83% | 86.59% | 9.96% | -16.62% | 12.02% | - |
| Operating CF / Revenue % | 13.58% | 13.03% | 8.5% | 5.3% | 9.14% | 1.42% | 18.5% | 9.62% | 9.44% | 12.21% | 11.67% |
| Net Income | 100.32M | 70.82M | -35.6M | -76.89M | -73.38M | -53.27M | 2.16M | -4.96M | 13.3M | 11.22M | -146.03M |
| Depreciation & Amortization | 241.65M | 187.56M | 221.64M | 237.3M | 200.6M | 157.38M | 132.95M | 144.14M | 103.31M | 121.42M | 277.67M |
| Stock-Based Compensation | 16.93M | 14.62M | 9.87M | 5.47M | 3.91M | 9.66M | -1.19M | 2.96M | 3.24M | 1.2M | 1.82M |
| Other Non-Cash Items | 25.67M | 74.7M | 48.86M | -11.55M | 54.44M | -2.39M | 10.97M | 24.24M | 8.08M | 16.82M | -2M |
| Working Capital Changes | -40.37M | -30.32M | -68.68M | -55.79M | -37.8M | -93.47M | 74.19M | -48.92M | -21.12M | -22.57M | -17.09M |
| Cash from Investing | -1.25B | -1.08B | -8.73M | 9.4M | -118.58M | -138.65M | -147.94M | -103.11M | -135.77M | -124.55M | -352.69M |
| Acquisitions (Net) | -165.94M | 0 | -235K | -12.93M | -18.57M | -650K | 0 | 0 | 0 | 0 | 0 |
| Purchase of Investments | -662.03M | -1.01B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sale of Investments | 51.38M | 61M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing | -411.36M | -6.61M | 83.44M | 122.11M | -28.49M | -58.31M | -19.64M | -10.28M | -68.86M | -81M | -306.7M |
| Cash from Financing | 969.26M | 817.5M | -134.74M | -129.06M | -42.92M | 94.11M | -8.81M | 2.69M | 37.6M | 4.76M | 226.66M |
| Dividends Paid | -170.8M | -163.52M | -120.89M | -76.28M | -51.12M | -22.79M | -27M | -62.61M | -59.97M | -55.78M | -51.68M |
| Common Dividends | -170.8M | -163.52M | -120.89M | -76.28M | -51.12M | -22.79M | -27M | -62.61M | -59.97M | -55.78M | -51.68M |
| Debt Issuance (Net) | -4M | -1000K | -1000K | -1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Share Repurchases | -9.76M | 238K | -14K | -469K | -20.7M | -382K | -23.11M | -89.89M | -76.58M | -30.66M | -20.94M |
| Other Financing | -5.31M | -4.98M | -382.64M | -34.72M | -33.93M | -29.04M | -724K | -17.98M | -8.42M | 1.71M | 9.77M |
| Net Change in Cash | 37.91M | 28.45M | 32.52M | -21.12M | -13.58M | -26.7M | 62.31M | 17.18M | 8.56M | 8.47M | -11.81M |
| Exchange Rate Effect | -26K | 62K | -91K | 7K | 154K | -74K | -90K | 145K | -77K | 149K | -140K |
| Cash at Beginning | 151.75M | 123.3M | 90.78M | 111.91M | 125.49M | 152.19M | 89.88M | 72.7M | 64.14M | 55.68M | 67.49M |
| Cash at End | 165.36M | 151.75M | 123.3M | 90.78M | 111.91M | 125.49M | 152.19M | 89.88M | 72.7M | 64.14M | 55.68M |
| Free Cash Flow | 235.49M | 165.88M | 84.15M | -1.26M | 76.25M | -61.78M | 90.85M | 24.62M | 39.91M | 84.55M | 68.37M |
| FCF Growth % | 57.6% | 97.13% | 6799.6% | -101.65% | 223.41% | -168% | 269.06% | -38.31% | -52.8% | 23.66% | - |
| FCF / Revenue % | 9.94% | 7.34% | 4.06% | -0.07% | 4.71% | -4.89% | 7.67% | 2.02% | 3.53% | 8.06% | 6.97% |
Healthcare labor cost inflation
According to the reported financial data, AHR's FFO to GAAP Net Income ratio has fluctuated wildly, reaching a high of 30.02 in 2024Q2 and a low of -15.30 in 2024Q3, illustrating that GAAP net income is a poor proxy for the company's actual cash-generating capacity.
The extreme variance in the FFO/NI ratio suggests that non-cash charges, likely related to depreciation and amortization of the integrated senior health campus assets, heavily distort bottom-line GAAP results. Investors should monitor this disconnect, as it implies that GAAP earnings provide little visibility into the underlying cash flow stability of the operating platform.
Based on the quarterly financial statements, AHR's dividend payout ratio relative to AFFO has been inconsistent, spiking to 1.51 in 2024Q4 and settling at 0.52 in 2026Q1, which indicates that the dividend is not always supported by recurring cash flow after accounting for necessary capital expenditures.
The fluctuation in the dividend-to-AFFO ratio highlights the sensitivity of the company's distributable cash to operational performance and maintenance requirements. While the 2026Q1 coverage appears more comfortable, the historical volatility suggests that the dividend may remain vulnerable to periods of elevated facility-level spending or labor-driven margin compression.
As reported in the company's cash flow statements, AHR consistently allocates significant capital to property maintenance, with quarterly CapEx reaching as high as $48.1M in 2025Q4, which directly reduces the pool of funds available for distribution to shareholders after accounting for operational needs.
The recurring nature of these capital expenditures, likely driven by the intensive requirements of maintaining integrated senior health campuses, acts as a persistent drag on AFFO. This suggests that the company's 'true' free cash flow is significantly lower than headline FFO, necessitating a cautious view on the sustainability of current payout levels.
Financial statements indicate that AHR's GAAP net income frequently diverges from FFO, with the company reporting a net loss of $31.8M in 2024Q4 while simultaneously generating $25.3M in FFO, confirming that depreciation and amortization charges significantly obscure the REIT's actual cash-based performance.
This distortion is typical for a REIT with heavy operational exposure, but the magnitude of the gap suggests that investors must prioritize FFO and AFFO to understand the business. The reliance on these non-GAAP metrics is essential, yet the underlying volatility in FFO suggests that even these adjusted figures are subject to significant operational swings.
Quick answers to the most common questions about buying AHR stock.
American Healthcare REIT, Inc. (AHR) generated $294.4M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
American Healthcare REIT, Inc. (AHR) generated $165.9M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
American Healthcare REIT, Inc. (AHR) spent $128.6M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, American Healthcare REIT, Inc. (AHR) returned $163.5M to shareholders via cash dividends and spent $0.2M on share repurchases. This shows the company's commitment to returning capital to its equity investors.